Can a urea cream beat vaseline for nail psoriasis?
NCT ID NCT07546032
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study tests a cream called PROXERA PSOMED 30, which contains 30% urea, for treating nail psoriasis. 21 adults with nail psoriasis will apply the cream to one nail and Vaseline to another nail twice daily for 24 weeks. Researchers will compare how much each nail improves using a standard severity score. The goal is to see if the cream works better than plain Vaseline at reducing nail symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PROXERA PSOMED 30 nail cream (30% urea)
- What this could lead to
- If it works, this could offer a simple, non-drug cream to ease nail psoriasis symptoms like thickening and discoloration.
- What could go wrong
- This is a very small early trial with only 21 people. The cream may not work better than Vaseline, and results may not apply to everyone with nail psoriasis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAIL PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Dermatologica Dipartimento di Medicina e Scienze dell'Invecchiamento Università G. D' Annunzio
RECRUITINGChieti, Italia, 66100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single cream tackle both skin and nail psoriasis?
- Can a daily patch fix your toenails? new trial aims to find out
- New pill shows promise for nail psoriasis in first human test
- Could a nail polish treat psoriasis? small trial tests tofacitinib lacquer
- Nail psoriasis injection study halted after just one person